Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta

Detalhes bibliográficos
Autor(a) principal: Gouveia, C
Data de Publicação: 2022
Outros Autores: Branco, J, Norte, S, Arcangelo, J, Alves, P, Pinto, M, Tavares, D
Tipo de documento: Artigo
Idioma: spa
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4467
Resumo: Introduction: Despite the current trend towards less aggressive therapeutic approaches, acute haematogenous osteomyelitis (AHO) continues to be a challenge and is associated with significant morbidity worldwide. Our aim was to determine if 80% compliance with current protocol was achieved, identify complications and associated risk factors and analyse trends in aetiology and management of AHO in children. Methods: We conducted a longitudinal, observational, single-centre study in patients with AHO aged less than 18 years admitted to a paediatric hospital, between 2008 and 2018, divided into 2 cohorts (before and after 2014). Demographic, clinical data and disease progression were analysed. Results: The study included 71 children with AHO, 56% male, with a median age of 3 years (interquartile range, 1-11). We found a 1.8-fold increase of cases in the last 5 years. The causative agent was identified in 37% of cases: MSSA (54%), MRSA (4%), Streptococcus pyogenes (19%), Kingella kingae (12%), Streptococcus pneumoniae (8%), and Neisseria meningitidis (4%). Complications were identified in 45% of patients and sequelae in 3.6%. In recent years, there was an increase in myositis (30% vs. 7%; p=0.02), septic arthritis (68% vs. 37.2%; p=0.012) and in the proportion of patients treated for less than 4 weeks (37% vs. 3.5%; p=0.012), with a similar sequelae rates. The risk factors for complications were age 3 or more years, CRP levels of 20mg/l or higher, time elapsed between onset and admission of 5 or more days and positive culture, although on multivariate analysis only positive culture was significant. The presence of complications was a risk factor for sequelae at 6 months. Conclusions: Our study confirms that AHO can be aggressive. The identification of risk factors for complications may be fundamental for management.
id RCAP_78b21042d9e261c0682c3ebc4c0fbac3
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4467
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente AltaAcute Haematogenous Osteomyelitis in Lisbon: An Unexpectedly High Association with Myositis and ArthritisOsteomielitisMiositisKingella kingaeChildHDE INF PEDHDE ORT PEDHDE PAT CLINIntroduction: Despite the current trend towards less aggressive therapeutic approaches, acute haematogenous osteomyelitis (AHO) continues to be a challenge and is associated with significant morbidity worldwide. Our aim was to determine if 80% compliance with current protocol was achieved, identify complications and associated risk factors and analyse trends in aetiology and management of AHO in children. Methods: We conducted a longitudinal, observational, single-centre study in patients with AHO aged less than 18 years admitted to a paediatric hospital, between 2008 and 2018, divided into 2 cohorts (before and after 2014). Demographic, clinical data and disease progression were analysed. Results: The study included 71 children with AHO, 56% male, with a median age of 3 years (interquartile range, 1-11). We found a 1.8-fold increase of cases in the last 5 years. The causative agent was identified in 37% of cases: MSSA (54%), MRSA (4%), Streptococcus pyogenes (19%), Kingella kingae (12%), Streptococcus pneumoniae (8%), and Neisseria meningitidis (4%). Complications were identified in 45% of patients and sequelae in 3.6%. In recent years, there was an increase in myositis (30% vs. 7%; p=0.02), septic arthritis (68% vs. 37.2%; p=0.012) and in the proportion of patients treated for less than 4 weeks (37% vs. 3.5%; p=0.012), with a similar sequelae rates. The risk factors for complications were age 3 or more years, CRP levels of 20mg/l or higher, time elapsed between onset and admission of 5 or more days and positive culture, although on multivariate analysis only positive culture was significant. The presence of complications was a risk factor for sequelae at 6 months. Conclusions: Our study confirms that AHO can be aggressive. The identification of risk factors for complications may be fundamental for management.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEGouveia, CBranco, JNorte, SArcangelo, JAlves, PPinto, MTavares, D2023-03-21T12:54:51Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4467spaAnales Pediatría.2022; 96:106-11410.1016/j.anpedi.2020.11.031info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-26T03:45:35Zoai:repositorio.chlc.min-saude.pt:10400.17/4467Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:46:11.494962Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
Acute Haematogenous Osteomyelitis in Lisbon: An Unexpectedly High Association with Myositis and Arthritis
title Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
spellingShingle Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
Gouveia, C
Osteomielitis
Miositis
Kingella kingae
Child
HDE INF PED
HDE ORT PED
HDE PAT CLIN
title_short Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
title_full Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
title_fullStr Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
title_full_unstemmed Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
title_sort Osteomielitis Hematógena Aguda en Lisboa: Asociación con Miositis y Artritis Inesperadamente Alta
author Gouveia, C
author_facet Gouveia, C
Branco, J
Norte, S
Arcangelo, J
Alves, P
Pinto, M
Tavares, D
author_role author
author2 Branco, J
Norte, S
Arcangelo, J
Alves, P
Pinto, M
Tavares, D
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Gouveia, C
Branco, J
Norte, S
Arcangelo, J
Alves, P
Pinto, M
Tavares, D
dc.subject.por.fl_str_mv Osteomielitis
Miositis
Kingella kingae
Child
HDE INF PED
HDE ORT PED
HDE PAT CLIN
topic Osteomielitis
Miositis
Kingella kingae
Child
HDE INF PED
HDE ORT PED
HDE PAT CLIN
description Introduction: Despite the current trend towards less aggressive therapeutic approaches, acute haematogenous osteomyelitis (AHO) continues to be a challenge and is associated with significant morbidity worldwide. Our aim was to determine if 80% compliance with current protocol was achieved, identify complications and associated risk factors and analyse trends in aetiology and management of AHO in children. Methods: We conducted a longitudinal, observational, single-centre study in patients with AHO aged less than 18 years admitted to a paediatric hospital, between 2008 and 2018, divided into 2 cohorts (before and after 2014). Demographic, clinical data and disease progression were analysed. Results: The study included 71 children with AHO, 56% male, with a median age of 3 years (interquartile range, 1-11). We found a 1.8-fold increase of cases in the last 5 years. The causative agent was identified in 37% of cases: MSSA (54%), MRSA (4%), Streptococcus pyogenes (19%), Kingella kingae (12%), Streptococcus pneumoniae (8%), and Neisseria meningitidis (4%). Complications were identified in 45% of patients and sequelae in 3.6%. In recent years, there was an increase in myositis (30% vs. 7%; p=0.02), septic arthritis (68% vs. 37.2%; p=0.012) and in the proportion of patients treated for less than 4 weeks (37% vs. 3.5%; p=0.012), with a similar sequelae rates. The risk factors for complications were age 3 or more years, CRP levels of 20mg/l or higher, time elapsed between onset and admission of 5 or more days and positive culture, although on multivariate analysis only positive culture was significant. The presence of complications was a risk factor for sequelae at 6 months. Conclusions: Our study confirms that AHO can be aggressive. The identification of risk factors for complications may be fundamental for management.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01T00:00:00Z
2023-03-21T12:54:51Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4467
url http://hdl.handle.net/10400.17/4467
dc.language.iso.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv Anales Pediatría.2022; 96:106-114
10.1016/j.anpedi.2020.11.031
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131545863192576